Müller V - Search Results

1

Role of HYAL1 expression in primary breast cancer in the formation of brain metastases.

Witzel I, Marx AK, Müller V, Wikman H, Matschke J, Schumacher U, Stürken C, Prehm P, Laakmann E, Schmalfeldt B, Milde-Langosch K, Oliveira-Ferrer L. Witzel I, et al. Among authors: muller v. Breast Cancer Res Treat. 2017 Apr;162(3):427-438. doi: 10.1007/s10549-017-4135-6. Epub 2017 Feb 6. Breast Cancer Res Treat. 2017. PMID: 28168629

2

Detection and clinical implications of early systemic tumor cell dissemination in breast cancer.

Pantel K, Müller V, Auer M, Nusser N, Harbeck N, Braun S. Pantel K, et al. Among authors: muller v. Clin Cancer Res. 2003 Dec 15;9(17):6326-34. Clin Cancer Res. 2003. PMID: 14695131

3

Prognostic and predictive impact of the HER-2/ neu extracellular domain (ECD) in the serum of patients treated with chemotherapy for metastatic breast cancer.

Müller V, Witzel I, Lück HJ, Köhler G, von Minckwitz G, Möbus V, Sattler D, Wilczak W, Löning T, Jänicke F, Pantel K, Thomssen C. Müller V, et al. Breast Cancer Res Treat. 2004 Jul;86(1):9-18. doi: 10.1023/B:BREA.0000032919.83803.48. Breast Cancer Res Treat. 2004. PMID: 15218357 Clinical Trial.

4

Detection and characterization of circulating microsatellite-DNA in blood of patients with breast cancer.

Schwarzenbach H, Müller V, Stahmann N, Pantel K. Schwarzenbach H, et al. Among authors: muller v. Ann N Y Acad Sci. 2004 Jun;1022:25-32. doi: 10.1196/annals.1318.005. Ann N Y Acad Sci. 2004. PMID: 15251935

5

Bone marrow micrometastases and circulating tumor cells: current aspects and future perspectives.

Müller V, Pantel K. Müller V, et al. Breast Cancer Res. 2004;6(6):258-61. doi: 10.1186/bcr942. Epub 2004 Sep 29. Breast Cancer Res. 2004. PMID: 15535856 Free PMC article. Review.

6

Circulating tumor cells in breast cancer: correlation to bone marrow micrometastases, heterogeneous response to systemic therapy and low proliferative activity.

Müller V, Stahmann N, Riethdorf S, Rau T, Zabel T, Goetz A, Jänicke F, Pantel K. Müller V, et al. Clin Cancer Res. 2005 May 15;11(10):3678-85. doi: 10.1158/1078-0432.CCR-04-2469. Clin Cancer Res. 2005. PMID: 15897564

7

Prognostic and predictive impact of soluble epidermal growth factor receptor (sEGFR) protein in the serum of patients treated with chemotherapy for metastatic breast cancer.

Müller V, Witzel I, Pantel K, Krenkel S, Lück HJ, Neumann R, Keller T, Dittmer J, Jänicke F, Thomssen C. Müller V, et al. Anticancer Res. 2006 Mar-Apr;26(2B):1479-87. Anticancer Res. 2006. PMID: 16619561 Free article. Clinical Trial.

8

Disseminated tumor cells in breast cancer: detection, characterization and clinical relevance.

Wölfle U, Müller V, Pantel K. Wölfle U, et al. Among authors: muller v. Future Oncol. 2006 Aug;2(4):553-61. doi: 10.2217/14796694.2.4.553. Future Oncol. 2006. PMID: 16922621 Review.

9

Recent translational research: circulating tumor cells in breast cancer patients.

Müller V, Hayes DF, Pantel K. Müller V, et al. Breast Cancer Res. 2006;8(5):110. doi: 10.1186/bcr1541. Breast Cancer Res. 2006. PMID: 16953898 Free PMC article. Review.

10

Detection of circulating tumor cells in peripheral blood of patients with metastatic breast cancer: a validation study of the CellSearch system.

Riethdorf S, Fritsche H, Müller V, Rau T, Schindlbeck C, Rack B, Janni W, Coith C, Beck K, Jänicke F, Jackson S, Gornet T, Cristofanilli M, Pantel K. Riethdorf S, et al. Among authors: muller v. Clin Cancer Res. 2007 Feb 1;13(3):920-8. doi: 10.1158/1078-0432.CCR-06-1695. Clin Cancer Res. 2007. PMID: 17289886

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,628 results

Search Page

Filters